This page includes the latest FDA filings for Pierre Fabre Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Pierre Fabre Pharmaceuticals Inc holds import registrations or U.S. agent authorizations in conjunction with the following organizations:
| Registration Number | 3012234772 | ||||
| FEI Number | 3012234772 | ||||
| Name | Kristen Snaguski | ||||
| Owner & Operator | Pierre Fabre Pharmaceuticals, Inc. | ||||
| Contact Address | 8 Campus Drive 2nd Floor Parsippany NJ 07054 US | ||||
| Official Correspondent |
| ||||
| US Agent |
| ||||
| Importing Logistics Registration |
| ||||
| Registration Status | 1 | ||||
| Initial Importer | N | ||||
| Registration Expiration | 2020-04-25 | ||||
| Registration Address | 8 CAMPUS DR STE 2 Parsippany, NJ 07054 US | ||||
| Establishment Type | Manufacture Medical Device |
| Registration Number | 3013144400 |
| FEI Number | 3013144400 |
| Name | PIERRE FABRE PHARMACEUTICALS, INC. |
| Owner & Operator | Pierre Fabre Pharmaceuticals, Inc. |
| Contact Address | 8 Campus Drive 2nd Floor Parsippany NJ 07054 US |
| Official Correspondent |
|
| Registration Status | 1 |
| Initial Importer | Y |
| Registration Expiration | 2020-04-25 |
| Registration Address | 8 CAMPUS DR STE 2 Parsippany, NJ 07054 US |
| Registration Number | 3012481408 |
| FEI Number | 3012481408 |
| Name | PIERRE FABRE MEDICAL DEVICES |
| Owner & Operator | Pierre Fabre Pharmaceuticals, Inc. |
| Contact Address | 8 Campus Drive 2nd Floor Parsippany NJ 07054 US |
| Official Correspondent |
|
| US Agent |
|
| Registration Status | 1 |
| Initial Importer | N |
| Registration Expiration | 2020-04-25 |
| Registration Address | 29 Avenue du Sidobre Castres Midi-Pyrenees, 81106 FR |
| Establishment Type | Complaint File Establishment per 21 CFR 820.198 |
Device Company | Device | Date |
|---|---|---|
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2023-04-08 |
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2021-10-23 |
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2021-09-03 |
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2020-04-23 |
| Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament, Pierre Fabre Medicament Production | Prescription Medication | 2020-02-01 |
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2019-12-25 |
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2019-11-01 |
| Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament, Pierre Fabre Medicament Production | Prescription Medication | 2019-10-11 |
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2019-08-15 |
| Pierre Fabre Pharmaceuticals, Inc. | Prescription Medication | 2018-12-27 |
| Pierre Fabre Pharmaceuticals, Inc. | TOLAK | 2017-03-15 |
PIERRE FABRE MEDICAL DEVICES [Pierre Fabre Pharmaceuticals, Inc.] | DEXERYL | 2016-10-12 |
Kristen Snaguski [Pierre Fabre Pharmaceuticals, Inc.] | DEXERYL | 2016-10-12 |
| Pierre Fabre Pharmaceuticals, Inc. | HEMANGEOL | 2014-04-14 |
| Pierre Fabre Pharmaceuticals, Inc. | 2007-07-01 | |
| Pierre Fabre Pharmaceuticals, Inc. | NAVELBINE | 2005-11-15 |
| NCAGE Code | 6RXV5 | PIERRE FABRE PHARMACEUTICALS, INC. |
| CAGE Code | 6RXV5 | PIERRE FABRE PHARMACEUTICALS, INC. |
| S.A.M. Registration | 6RXV5 [968997101] | PIERRE FABRE PHARMACEUTICALS, INC. |